What FDA-Approved Treatments Help Idiopathic Hypersomnia?

Before starting any medication, your doctor should confirm your diagnosis of idiopathic hypersomnia and rule out other causes of sleepiness, such as sleep apnea, insufficient sleep, or medication side effects.

Yes, there is now a medication specifically approved to treat idiopathic hypersomnia, meaning you will not necessarily just be given traditional stimulants. In 2021, the U.S. FDA approved lower-sodium oxybate (often known by the brand name Xywav) as the first and only medication indicated specifically for idiopathic hypersomnia in adults ^[1]. However, sleep specialists also frequently prescribe other wake-promoting medications and traditional stimulants “off-label” as first-line options to effectively manage excessive daytime sleepiness ^[2].

The U.S. FDA-Approved Treatment: Lower-Sodium Oxybate

Lower-sodium oxybate is a central nervous system depressant—meaning it slows down brain activity—that is taken at night ^[1].

How Well Does It Work?

In the main clinical trial for adults with idiopathic hypersomnia, patients taking lower-sodium oxybate experienced significant improvements ^[3][4].

On the Epworth Sleepiness Scale (a standard measure where higher scores mean more sleepiness), participants’ average scores dropped from 15.7 (markedly elevated sleepiness) to 6.1 (normal range) ^[3]. It is important to note this average drop occurred during an “open-label” phase where everyone knew they were taking the drug and their dose was being adjusted to see what worked best.

To prove the drug truly works, the trial used a “randomized-withdrawal” phase: some patients who were doing well on the medication were secretly switched to a placebo (a harmless, inactive pill), while others stayed on the real drug. Those who continued the actual medication maintained their alertness significantly better than those switched to the placebo ^[3]. The medication has also been shown to improve the overall severity of the condition ^[4].

Important Safety Warnings and the Specialized Program

While effective, lower-sodium oxybate carries serious risks. Because it can cause central nervous system and respiratory depression (slowed breathing) and has the potential for misuse, it is only available through a restricted safety program ^[1].

Important Safety Information:
Mixing lower-sodium oxybate with alcohol or sedative-hypnotic drugs is dangerous and contraindicated ^[1]. Combining it with opioids, benzodiazepines, other sleep medicines, or central nervous system depressants can cause profound sedation, severely slowed breathing, low blood pressure, fainting, or even death ^[1]. You must disclose all prescription, over-the-counter, and recreational substances to your doctor.

In the clinical trial, common side effects included nausea, headaches, dizziness, anxiety, and vomiting ^[3][4]. About 14% of patients stopped the medication during the dose-adjustment and stable-treatment phases because of side effects ^[3].

Lower-sodium oxybate requires specific nighttime dosing routines. Patients often take one or two doses at night, which may require setting an alarm to wake up for the second dose. The medication must be stored securely, and you should never adjust your dose on your own.

Off-Label Wake-Promoting Agents and Stimulants

Even though lower-sodium oxybate is the only FDA-approved medication for idiopathic hypersomnia, the American Academy of Sleep Medicine (AASM) guidelines evaluate other medications approved for similar sleep disorders ^[2]. Prescribing these for idiopathic hypersomnia is called off-label use, a standard medical practice when doctors believe a treatment is appropriate.

• Modafinil: The 2021 AASM guidelines strongly recommend modafinil for adults with idiopathic hypersomnia ^[2]. It is a wake-promoting agent that works differently than traditional stimulants and has placebo-controlled evidence showing it improves daytime sleepiness ^[5]. Safety notes: Modafinil can reduce the effectiveness of hormonal birth control and carries rare risks of serious rashes or psychiatric side effects ^[6].
• Traditional Stimulants: Medications like methylphenidate (e.g., Ritalin) are conditionally suggested by the AASM guidelines, meaning there is less certainty in the evidence for idiopathic hypersomnia, but they may still be useful ^[2]. Safety notes: Doctors carefully monitor their use due to potential side effects like increased blood pressure, rapid heart rate, insomnia, appetite loss, and concerns about misuse or dependence ^[6].
• Other Options: The guidelines also conditionally suggest pitolisant (a medication working on histamine), standard sodium oxybate, and the antibiotic clarithromycin ^[2]. However, the evidence for clarithromycin in idiopathic hypersomnia is considered insufficient, and it is not a routine treatment ^[5]. Safety notes: Pitolisant and clarithromycin both have risks of heart-rhythm changes (QT prolongation) and drug interactions ^[6].

Driving and Safety

No matter which medication you try, never assume it makes you safe to drive. You should not drive or perform hazardous work when you feel sleepy or impaired. Always discuss your driving safety with your doctor, as clinical trial averages do not guarantee your personal reaction to a medication.

Your doctor will work with you to choose the best treatment based on your most disruptive symptoms—whether that is falling asleep during the day, sleeping for unusually long periods, or experiencing severe sleep inertia (extreme grogginess and difficulty fully waking up). Finding the right medication and dose often requires time and patience.